The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD

NCT07285850 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

HCC - Hepatocellular Carcinoma

Interventions

DRUG: Sequential treatment of bevacizumab combined with atezolizumab (sequential group)
DRUG: Simultaneous treatment of bevacizumab combined with atezolizumab (same period group)

Sponsor

Eastern Hepatobiliary Surgery Hospital